Sheldon L. Koenig - 19 Sep 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Sheldon L. Koenig
Issuer symbol
ESPR
Transactions as of
19 Sep 2022
Net transactions value
-$23,548
Form type
4
Filing time
20 Sep 2022, 16:08:25 UTC
Previous filing
08 Aug 2022
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale $23,548 -3,394 -1.7% $6.94 198,257 19 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.
F2 Consists of 198,257 shares of common stock held, including 2,880 shares acquired in Esperion's Employee Stock Purchase Plan on August 31, 2022.